Effect of degree of urbanisation on age and sex-specific asthma prevalence in Swedish preschool children.
BACKGROUND
There are few studies on age and sex-specific asthma prevalence in the age range 1-6 years. The purpose of this report was to estimate age and sex specific asthma prevalence in preschool children and to analyse the influence of possible demographic and geographic determinants.


METHODS
All 70 allergen avoidance day-care centres and 140 matched ordinary day-care centres across Sweden were sampled. The parents of all 8,757 children attending these day-care centres received the International Study of Asthma and Allergies in Childhood (ISAAC) written questionnaire, supplemented with questions on medical treatment, physician assessed asthma diagnosis, and other asthma related questions. The response rate was 68%.


RESULTS
The age specific asthma prevalence, adjusted for the underlying municipality population size, was among boys 9.7% at age 1, 11.1% at age 2, 11.4 at age 3, 10.5 at age 4, 8.7 at age 5, and 6.4 at age 6. The corresponding proportions among girls were 8.9%, 9.9%, 9.8%, 8.8%, 7.0%, and 5.0%, on average 9.6% for boys and 8.2% for girls, altogether 8.9%. In addition to age and sex the prevalence increased by municipality population density, a proxy for degree of urbanisation. Moreover, there was a remaining weak geographical gradient with increasing prevalence towards the north and the west.


CONCLUSIONS
The age-specific asthma prevalence was curvilinear with a peak around age 3 and somewhat higher for boys than for girls. The asthma prevalence increased in a slowly accelerating pace by municipality population density as a proxy for degree of urbanisation.
Bröms
Kristina
K
Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden. kristina.broms@pubcare.uu.se
Norbäck
Dan
D
Eriksson
Margaretha
M
Sundelin
Claes
C
Svärdsudd
Kurt
K
D000367:Age Factors; D001249:Asthma / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D015995:Prevalence; D011795:Surveys and Questionnaires; D013548:Sweden / Q000453:epidemiology; D014507:Urbanization
Lancet. 2001 Jun 9;357(9271):1821-5
11410189
Respir Med. 1998 Feb;92(2):316-24
9616532
Clin Exp Allergy. 2002 Oct;32(10):1405-12
12372117
J Investig Allergol Clin Immunol. 2005;15(3):201-10
16261957
QJM. 2004 Aug;97(8):489-98
15256606
Indoor Air. 2006 Jun;16(3):227-35
16683941
Pediatrics. 1999 Apr;103(4 Pt 1):753-8
10103298
Pediatrics. 2001 Oct;108(4):943-8
11581448
Am J Respir Crit Care Med. 2007 May 15;175(10):1078-85
17290040
Eur Respir J. 1997 Aug;10(8):1780-6
9272919
Pediatr Allergy Immunol. 2007 May;18(3):209-16
17432999
J Allergy Clin Immunol. 2004 Oct;114(4):755-60
15480312
Clin Rev Allergy Immunol. 2002 Feb;22(1):33-44
11803801
Respir Med. 2009 Jan;103(1):104-8
18760577
Occup Environ Med. 2004 Jul;61(7):609-15
15208377
J Asthma. 2007 Apr;44(3):197-202
17454338
Indoor Air. 2005;15 Suppl 10:48-55
15926944
Eur Respir J. 1995 Mar;8(3):483-91
7789502
Int J Epidemiol. 1997 Jun;26(3):610-9
9222787
Eur Respir J. 1998 Nov;12(5):1105-12
9864005
Eur Respir J. 1998 Aug;12(2):432-7
9727797
Thorax. 2007 Sep;62(9):758-66
17504817
Occup Environ Med. 2009 Feb;66(2):90-8
19151227
N Engl J Med. 1995 Jan 19;332(3):133-8
7800004
Allergy. 2006 May;61(5):556-62
16629784
Allergy. 2006 Apr;61(4):447-53
16512807
Pediatr Allergy Immunol. 2007 Mar;18(2):135-41
17338786
Lancet. 2006 Aug 26;368(9537):733-43
16935684
Int Arch Occup Environ Health. 2007 Jan;80(3):207-16
16821046
Eur Respir J. 2001 May;17(5):881-6
11488320